JPMorgan Chase & Co. Cuts HCA Healthcare (NYSE:HCA) Price Target to $490.00

HCA Healthcare (NYSE:HCA) had its target price lowered by equities researchers at JPMorgan Chase & Co. from $535.00 to $490.00 in a note issued to investors on Tuesday,MarketScreener reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 20.76% from the stock’s previous close.

A number of other research firms have also recently weighed in on HCA. Truist Financial decreased their price target on HCA Healthcare from $546.00 to $535.00 and set a “buy” rating for the company in a report on Monday, April 27th. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Wells Fargo & Company cut their price objective on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a report on Monday, April 27th. Argus lowered their target price on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Finally, Mizuho upped their target price on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research report on Wednesday, February 25th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $515.77.

HCA Healthcare Trading Down 4.0%

HCA traded down $17.02 during trading on Tuesday, hitting $405.77. 245,089 shares of the company’s stock were exchanged, compared to its average volume of 1,122,558. The firm has a market cap of $90.02 billion, a P/E ratio of 14.04, a price-to-earnings-growth ratio of 1.34 and a beta of 1.18. The stock has a 50 day moving average price of $476.49 and a 200 day moving average price of $485.66. HCA Healthcare has a 1 year low of $330.00 and a 1 year high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same period last year, the company posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts forecast that HCA Healthcare will post 30.07 earnings per share for the current fiscal year.

Insider Transactions at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 1,694 shares of the business’s stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the transaction, the executive vice president owned 8,853 shares of the company’s stock, valued at approximately $4,721,924.61. The trade was a 16.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Holos Integrated Wealth LLC bought a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $29,000. Palisade Asset Management LLC acquired a new stake in HCA Healthcare in the 3rd quarter valued at approximately $26,000. Ares Financial Consulting LLC acquired a new position in HCA Healthcare during the 4th quarter worth $31,000. Cedar Mountain Advisors LLC acquired a new position in shares of HCA Healthcare during the first quarter valued at $33,000. Finally, MCF Advisors LLC lifted its holdings in HCA Healthcare by 213.0% in the fourth quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after purchasing an additional 49 shares during the period. Institutional investors own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.